| Company Name: |
VDM Biochemicals
|
| Tel: |
0330-2528181 |
| Email: |
sales@vdmbio.com |
| Products Intro: |
Product Name:HNHA
CAS:926908-04-5
Purity:>=95%
|
| Company Name: |
Tianjin Derchemist Science & Technology Co., Ltd.
|
| Tel: |
22-58627059 13920586291 |
| Email: |
zdcomcon@126.com |
| Products Intro: |
Product Name:1-(3-chlorophenyl)-8-phenylnaphthalene
CAS:926908-04-5
Purity:95% Package:25KG/10KG/5KG/1KG/500G/100G
|
|
| Product Name: | HNHA | | Synonyms: | HNHAHDAC inhibitor;HNHA;N-hydroxy-7-(2-naphthalenylthio)-Heptanamide;Heptanamide, N-hydroxy-7-(2-naphthalenylthio)-;N-Hydroxy-7-(naphthalen-2-ylthio)heptanamide;Histone deacetylases,HIF/HIF Prolyl-Hydroxylase,inhibit,HNHA,Inhibitor,HIF-PH,HIFs,FM3A cells,MCF-7 cells,Anti-cancer activity,Matrix metalloproteinases,Breast cancer,Hypoxia-inducible factors,MMP,HDAC | | CAS: | 926908-04-5 | | MF: | C17H21NO2S | | MW: | 303.42 | | EINECS: | | | Product Categories: | Other enzyme inhibitors and activators;Other Enzyme Inhibitors. | | Mol File: | 926908-04-5.mol |  |
| storage temp. | under inert gas (nitrogen or Argon) at 2-8°C | | solubility | ≤20mg/ml in ethanol;20mg/ml in DMSO;20mg/ml in dimethyl formamide | | form | Crystalline solid | | Sensitive | Light Sensitive |
| Description | HNHA is a cell-permeable inhibitor of histone deacetylase (HDAC) activity (IC50 = 100 nM). In human fibrosarcoma HT1080 cells, it induces histone hyperacetylation and p21 transcription with concomitant inhibition of cell cycle progression (IC50 ~ 7.5 μM). HNHA is at least as effective as SAHA in inhibiting tumor growth in a murine xenograph model in vivo. HNHA also blocks the growth of human umbilical vein endothelial cells (HUVECs) and prevents tube formation and migration of HUVECs in response to vascular endothelial growth factor (VEGF). It also blocks retinal neovascularization and choroidal angiogenesis in mice. | | Uses | A cell-permeable hydroxyamide-based SAHA analog that potently inhibits histone deacetylase (HDAC) activity | | Definition | ChEBI: N-hydroxy-7-(2-naphthalenylthio)heptanamide is a member of naphthalenes. | | in vitro | previous study found that hnha was able to inhibit in-vitro hdac enzyme activity as well as proliferation of human fibrosarcoma cells (ht1080). in addition, treatment of cells with hnha could elicite histone hyperacetylation resulting in an up-regulation of cell cycle arrest, p21 transcription, and an inhibition of ht1080 cell invasion [1]. | | in vivo | the effects of hnha on human cancer cells bearing xenograph mice was examined. results showed that as expected, hnha could dramatically reduce tumor volume as to (vehicle) control. in addition, hnha had a stronger potency than that of saha, which implied that the pharmacological potency of hnha was better than saha in vivo [1]. | | IC 50 | 100 nm | | references | 1. kim, d.h.,lee, j.,kim, k.n., et al. anti-tumor activity of n-hydroxy-7-(2-naphthylthio) heptanomide, a novel histone deacetylase inhibitor. biochemical and biophysical research communications 356, 233-238 (2007). |
| | HNHA Preparation Products And Raw materials |
|